MY143584A - Non-anilinic derivatives of isothiazol-3(2h)-one 1, 1-dioxides as liver x receptor modulators - Google Patents

Non-anilinic derivatives of isothiazol-3(2h)-one 1, 1-dioxides as liver x receptor modulators

Info

Publication number
MY143584A
MY143584A MYPI20063260A MY143584A MY 143584 A MY143584 A MY 143584A MY PI20063260 A MYPI20063260 A MY PI20063260A MY 143584 A MY143584 A MY 143584A
Authority
MY
Malaysia
Prior art keywords
liver
isothiazol
dioxides
receptor modulators
anilinic
Prior art date
Application number
Inventor
Marianne Swanson
Eva-Lotte Lindstedt
Lars Weidolf
Anders Broo
Lanna Li
Pernilla Sandberg
Robert Judkins
Patrick Holm
Kay Brickmann
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to MYPI20063260 priority Critical patent/MY143584A/en
Publication of MY143584A publication Critical patent/MY143584A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

THE PRESENT INVENTION RELATES TO CERTAIN NOVEL COMPOUNDS OF THE FORMULA I TO PROCESSES FOR PREPARING SUCH COMPOUNDS, TO THEIR THE UTILITY IN MODULATION OF NUCLEAR HORMONE RECEPTORS LIVER X RECEPTOR (LXR) Α (NR1H3) AND/OR Β (NR1H2) AND IN TREATING AND/OR PREVENTING CLINICAL CONDITIONS INCLUDING CARDIOVASCULAR DISEASES SUCH AS ATHEROSCLEROSIS; INFLAMMATORY DISEASES, ALZHEIMER’S DISEASE, LIPID DISORDERS (DYSLIPIDEMIAS) WHETHER OR NOT ASSOCIATED WITH INSULIN RESISTANCE, TYPE 2 DIABETES AND OTHER MANIFESTATIONS OF THE METABOLIC SYNDROME, TO METHODS FOR THEIR THERAPEUTIC USE AND TO PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
MYPI20063260 2006-07-07 2006-07-07 Non-anilinic derivatives of isothiazol-3(2h)-one 1, 1-dioxides as liver x receptor modulators MY143584A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI20063260 MY143584A (en) 2006-07-07 2006-07-07 Non-anilinic derivatives of isothiazol-3(2h)-one 1, 1-dioxides as liver x receptor modulators

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI20063260 MY143584A (en) 2006-07-07 2006-07-07 Non-anilinic derivatives of isothiazol-3(2h)-one 1, 1-dioxides as liver x receptor modulators

Publications (1)

Publication Number Publication Date
MY143584A true MY143584A (en) 2011-05-31

Family

ID=45020826

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20063260 MY143584A (en) 2006-07-07 2006-07-07 Non-anilinic derivatives of isothiazol-3(2h)-one 1, 1-dioxides as liver x receptor modulators

Country Status (1)

Country Link
MY (1) MY143584A (en)

Similar Documents

Publication Publication Date Title
UA91992C2 (en) Non-anilinic derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulators
TW200507836A (en) Therapeutic agents
MXPA06000414A (en) Pyrrole-2, 5-dione derivatives as liver x receptor modulators.
NO20073248L (en) Derivatives of isothiazole-3 (2H) -one 1,1-dioxides that supply X receptor modulators
EP3459935A1 (en) Trk-inhibiting compound
SE0500056D0 (en) Therapeutic agents 4
MY147588A (en) (3-amino-1,2,3,4-tetrahydro-9h-carbazol-9-yl)-acetic acid derivatives
TW200508180A (en) Therapeutic agents
RU2003114748A (en) NEW COMPOUNDS NOT IMIDAZOLE
MA32898B1 (en) POSITIVE ALLOSTERIC MODULATORS OF ARYLMETHYLBENZOQUINAZOLINONE M1 RECEPTOR
MXPA05013712A (en) Propionic acid derivatives useful in the treatment of lipid disorders.
BR112012027640A2 (en) compound, pharmaceutical composition, use of a compound, and methods of preparing a pharmaceutical composition, inhibiting the function of 11betahydroxysteroid dehydrogenase type 1 and treating or preventing a disorder
MXPA04006003A (en) Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (ppar).
BRPI0606110A2 (en) substituted arylamine compounds and their use as 5 - ht6 modulators
WO2008073451A3 (en) Benzoimidazole derivatives as sirtuin (sir) modulating compounds
BRPI0717023B8 (en) thiazole pyrazolopyrimidine, its use, and pharmaceutical composition
WO2010018109A3 (en) Substituted aminotetralines
SE0500058D0 (en) Therapeutic agents 5
BRPI1007350B8 (en) bicyclic heterocyclic spiro compounds
MX2009005507A (en) Spiro-piperidine derivatives.
WO2008132552A3 (en) Omega-3 lipid compounds
BR0318242A (en) substituted azabicyclic hexane derivatives as muscarinic receptor antagonists and process for their preparation
MY143584A (en) Non-anilinic derivatives of isothiazol-3(2h)-one 1, 1-dioxides as liver x receptor modulators
EP3366686A3 (en) Inhibitors of diacylglycerol o-acyltransferase 1 (dgat-1) and uses thereof
MX2009005504A (en) Spiro-piperidine derivatives as via receptor antagonists.